Evidence map›Paper›PMID 36347933›Full record

ArticleJournal of exposure science & environmental epidemiology2022

Developing an internal threshold of toxicological concern (iTTC).

Jon A Arnot, Liisa Toose, James M Armitage, Alessandro Sangion, Alexandra Looky, Trevor N Brown, Li Li, Richard A Becker

Erratum issuedAbstract read
In one paragraph

Article in Journal of exposure science & environmental epidemiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Incorporating new approach methods (NAMs) data in dose-response assessments: The future is now!Journal of toxicology and environmental health. Part B, Critical reviews · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Jon A ArnotARC Arnot Research and Consulting Inc., Toronto, ON, Canada. jon@arnotresearch.com.ORCID http://orcid.org/0000-0002-4295-4270
Liisa TooseARC Arnot Research and Consulting Inc., Toronto, ON, Canada.
James M ArmitageARC Arnot Research and Consulting Inc., Toronto, ON, Canada.
Alessandro SangionARC Arnot Research and Consulting Inc., Toronto, ON, Canada.
Alexandra LookyARC Arnot Research and Consulting Inc., Toronto, ON, Canada.
Trevor N BrownARC Arnot Research and Consulting Inc., Toronto, ON, Canada.
Li LiSchool of Public Health, University of Nevada Reno, Reno, NV, USA.
Richard A BeckerAmerican Chemistry Council, Washington, DC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThreshold of Toxicological Concern (TTC) approaches are used for chemical safety assessment and risk-based priority setting for data poor chemicals. TTCs are derived from in vivo No Observed Effect Level (NOEL) datasets involving an external administered dose from a single exposure route, e.g., oral intake rate. Thus, a route-specific TTC can only be compared to a route-specific exposure estimate and such TTCs cannot be used for other exposure scenarios such as aggregate exposures.

objectiveDevelop and apply a method for deriving internal TTCs (iTTCs) that can be used in chemical assessments for multiple route-specific exposures (e.g., oral, inhalation or dermal) or aggregate exposures.

methodsChemical-specific toxicokinetics (TK) data and models are applied to calculate internal concentrations (whole-body and blood) from the reported administered oral dose NOELs used to derive the Munro TTCs. The new iTTCs are calculated from the 5th percentile of cumulative distributions of internal NOELs and the commonly applied uncertainty factor of 100 to extrapolate animal testing data for applications in human health assessment.

resultsThe new iTTCs for whole-body and blood are 0.5 nmol/kg and 0.1 nmol/L, respectively. Because the iTTCs are expressed on a molar basis they are readily converted to chemical mass iTTCs using the molar mass of the chemical of interest. For example, the median molar mass in the dataset is 220 g/mol corresponding to an iTTC of 22 ng/L-blood (22 pg/mL-blood). The iTTCs are considered broadly applicable for many organic chemicals except those that are genotoxic or acetylcholinesterase inhibitors. The new iTTCs can be compared with measured or estimated whole-body or blood exposure concentrations for chemical safety screening and priority-setting. SIGNIFICANCE: Existing Threshold of Toxicological Concern (TTC) approaches are limited in their applications for route-specific exposure scenarios only and are not suitable for chemical risk and safety assessments under conditions of aggregate exposure. New internal Threshold of Toxicological Concern (iTTC) values are developed to address data gaps in chemical safety estimation for multi-route and aggregate exposures.

Indexed as

ToxicokineticsAnimalsCholinesterase InhibitorsHumansMutagensNo-Observed-Adverse-Effect LevelRisk AssessmentToxicity TestsCholinesterase InhibitorsMutagensExposure modeling, Dermal exposure, Dietary exposure, Inhalation exposure, New approach methodologies (NAMs), PBPK modeling

Identifiers

PMID36347933
PMCPMC9731903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.